A highly diversified pharmaceutical company based outside of Europe has grown by acquisition and as a consequence has developed a range of quality management systems (QMS) and inherited a number of others.
It consisted of a number of sites managed directly by the organisation and nearly 50 subsidiaries that were managing the sale of major products.
These subsidiaries often used local contractors to manufacture other products for the local market only. In addition, the company strategy was to increasingly outsource more of its activities, with only a very few sites managed directly by the company.
Download this case study to find out more.